Nutrigenomics and nutrigenetics: The emerging faces of nutrition

FASEB Journal

Volumn 19, Issue 12, 2005, Pages 1602-1616

  Mutch, David M ^a,b,c   Wahli, Walter ^b   Williamson, Gary ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Coronary heart disease; Diabetes; Integrative metabolism; Metabolomics; Nutrient gene interaction; Polymorphism; Systems biology

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; FATTY ACID BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHYTOSTEROL; POLYUNSATURATED FATTY ACID; ROSIGLITAZONE; SITOSTEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1A;

CARCINOGENESIS; COMPUTER PROGRAM; DIETARY INTAKE; DISORDERS OF CHOLESTEROL METABOLISM; GENETIC POLYMORPHISM; GENETICS; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL TECHNOLOGY; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRIENT; NUTRIGENETICS; NUTRIGENOMICS; NUTRITION; PRIORITY JOURNAL; REVIEW; SITOSTEROLEMIA;

ANIMALS; CORONARY DISEASE; DIABETES MELLITUS; DNA, COMPLEMENTARY; FOOD TECHNOLOGY; GENETIC PREDISPOSITION TO DISEASE; GENOME; HEALTH FOOD; HUMANS; METABOLISM; MODELS, BIOLOGICAL; NUTRITION PHYSIOLOGY; POLYMORPHISM, GENETIC; SYSTEMS BIOLOGY; VARIATION (GENETICS);

EID: 26444493132     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.05-3911rev     Document Type: Review

References (147)

1. Kaput, J. (2004) Diet-disease gene interactions. Nutrition 20, 26-31
2. Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) The sequence of the human genome. Science 291, 1304-1351
3. McPherson, J. D., Marra, M., Hillier, L., Waterston, R. H., Chinwalla, A., Wallis, J., Sekhon, M., Wylie, K., Mardis, E. R., Wilson, R. K., et al. (2001) A physical map of the human genome. Nature (London) 409, 934-941
4. Okazaki, Y., Furuno, M., Kasukawa, T., Adachi, J., Bono, H., Kondo, S., Nikaido, I., Osato, N., Saito, R., Suzuki, H., et al. (2002) Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature (London) 420, 563-573
5. Waterston, R. H., Lindblad-Toh, K., Birney, E., Rogers, J., Abril, J. F., Agarwal, P., Agarwala, R., Ainscough, R., Alexandersson, M., An, P., et al. (2002) Initial sequencing and comparative analysis of the mouse genome. Nature (London) 420, 520-562
6. Gibbs, R. A., Weinstock, G. M., Metzker, M. L., Muzny, D. M., Sodergren, E. J., Scherer, S., Scott, G., Steffen, D., Worley, K. C., Burch, P. E., et al. (2004) Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature (London) 428, 493-521
7. Mooser, V., and Ordovas, J. M. (2003) 'Omic' approaches and lipid metabolism: are these new technologies holding their promises? Curr. Opin. Lipidol. 14, 115-119
8. Kenzelmann, M., Klaren, R., Hergenhahn, M., Bonrouhi, M., Grone, H. J., Schmid, W., and Schutz, G. (2004) High-accuracy amplification of nanogram total RNA amounts for gene profiling. Genomics 83, 550-558
9. Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., Aach, J., Ansorge, W., Ball, C. A., Causton, H. C., et al. (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29, 365-371
10. Edgar, R., Domrachev, M., and Lash, A. E. (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207-210
11. Wheeler, D. L., Church, D. M., Lash, A. E., Leipe, D. D., Madden, T. L., Pontius, J. U., Schuler, G. D., Schriml, L. M., Tatusova, T. A., Wagner, L., et al. (2001) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 29, 11-16
12. Munoz, E. T., Bogarad, L. D., and Deem, M. W. (2004) Microarray and EST database estimates of mRNA expression levels differ: The protein length versus expression curve for C. elegans. BMC Genomics 5(1), 30
13. Cahill, D. J., and Nordhoff, E. (2003) Protein arrays and their role in proteomics. Adv. Biochem. Eng. Biotechnol. 83, 177-187
14. Corthals, G. L., Wasinger, V. C., Hochstrasser, D. F., and Sanchez, J. C. (2000) The dynamic range of protein expression: a challenge for proteomic research. Electrophoresis 21, 1104-1115
15. Arab, L. (2004) Individualized nutritional recommendations: do we have the measurements needed to assess risk and make dietary recommendations? Proc. Nutr. Soc. 63, 167-172
16. Mendes, P. (2002) Emerging bioinformatics for the metabolome. Brief. Bioinform. 3, 134-145
17. Rabilloud, T. (2002) Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2, 3-10
18. Rose, K., Bougueleret, L., Baussant, T., Bohm, G., Bold, P., Colinge, J., Cusin, I., Gaertner, H., Gleizes, A., Heller, M., et al. (2004) Industrial-scale proteomics: from liters of plasma to chemically synthesized proteins. Proteomics 4, 2125-2150
19. Roberts, M. A., Mutch, D. M., and German, J. B. (2001) Genomics: food and nutrition. Curr. Opin. Biotechnol. 12, 516-522
20. Zeisel, S. H., Allen, L. H., Coburn, S. P., Erdman, J. W., Failla, M. L., Freake, H. C., King, J. C., and Storch, J. (2001) Nutrition: a reservoir for integrative science. J. Nutr. 131, 1319-1321
21. van der Meer-van Kraaij, C., Kramer, E., Jonker-Termont, D., Katan, M. B., van der Meer, R., and Keijer, J. (2005) Differential gene expression in rat colon by dietary heme and calcium. Carcinogenesis 26, 73-79
22. Griffin, J. L., Bonney, S. A., Mann, C., Hebbachi, A. M., Gibbons, G. F., Nicholson, J. K., Shoulders, C. C., and Scott, J. (2004) An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver. Physiol. Genomics 17, 140-149
23. Hirai, M. Y., Yano, M., Goodenowe, D. B., Kanaya, S., Kimura, T., Awazuhara, M., Arita, M., Fujiwara, T., and Saito, K. (2004) Integration of transcriptomics and metabolomics for understanding of global responses to nutritional stresses in Arabidopsis thaliana. Proc. Natl. Acad. Sci. USA 101, 10205-10210
24. Mutch, D. M., Grigorov, M., Berger, A., Fay, L. B., Roberts, M. A., Watkins, S. M., Williamson, G., and German, J. B. (2005) An integrative metabolism approach identifies stearoyl-CoA desaturase as a target for an arachidonate-enriched diet. FASEB J.
25. Nicholson, J. K., Holmes, E., Lindon, J. C., and Wilson, I. D. (2004) The challenges of modeling mammalian biocomplexity. Nat. Biotechnol. 22, 1268-1274
26. Butcher, E. C., Berg, E. L., and Kunkel, E. J. (2004) Systems biology in drug discovery. Nat. Biotechnol. 22, 1253-1259
27. van Ommen, B. (2004) Nutrigenomics: exploiting systems biology in the nutrition and health arenas. Nutrition 20, 4-8
28. Ordovas, J. M., and Mooser, V. (2004) Nutrigenomics and nutrigenetics. Curr. Opin. Lipidol. 15, 101-108
29. Muller, M., and Kersten, S. (2003) Nutrigenomics: goals and strategies. Nat. Rev. Genet. 4, 315-322
30. Ordovas, J. M., and Corella, D. (2004) Nutritional genomics. Annu. Rev. Genomics Hum. Genet. 5, 71-118
31. Kaput, J., and Rodriguez, R. L. (2004) Nutritional genomics: the next frontier in the postgenomic era. Physiol. Genomics 16, 166-177
32. Jimenez-Sanchez, G., Childs, B., and Valle, D. (2001) Human disease genes. Nature (London) 409, 853-855
33. Goppert, F. (1917) Galaktosurie nach Milchzuckergabe bei angeborenem, familiaerem chronischem Leberleiden. Klin. Wschr. 54, 473-477
34. Folling, A. (1934) Ueber Ausscheidung von Phenylbrenztraubensaeure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillitaet. Ztschr. Physiol. Chem. 227, 169-176
35. Gillies, P. J. (2003) Nutrigenomics: the Rubicon of molecular nutrition. J. Am. Diet. Assoc. 103, S50-S55
36. Segal, E., Friedman, N., Koller, D., and Regev, A. (2004) A module map showing conditional activity of expression modules in cancer. Nat. Genet. 36, 1090-1098
37. Willerson, J. T., and Ridker, P. M. (2004) Inflammation as a cardiovascular risk factor. Circulation 109, 112-10
38. Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J., Kwiterovich, P., Shan, B., Barnes, R., and Hobbs, H. H. (2000) Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290, 1771-1775
39. Bodzioch, M., Orso, E., Klucken, J., Langmann, T., Boucher, A., Diederich, W., Drobnik, W., Barlage, S., Buchler, C., Porsch-Ozcurumez, M., et al. (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22, 347-351
40. Browning, L. M. (2003) n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease. Proc. Nutr. Soc. 62, 447-453
41. Di Minno, G., Tufano, A., Garofano, T., and Di Minno, M. N. (2002) Polyunsaturated fatty acids, thrombosis and vascular disease. Pathophysiol. Haemost. Thromb. 32, 361-364
42. Stulnig, T. M. (2003) Immunomodulation by polyunsaturated fatty acids: mechanisms and effects. Int. Arch. Allergy Immunol. 132, 310-321
43. Prescott, S. L., and Calder, P. C. (2004) N-3 polyunsaturated fatty acids and allergic disease. Curr. Opin. Clin. Nutr. Metab. Care 7, 123-129
44. Bourre, J. M. (2004) Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J. Nutr. Health Aging 8, 163-174
45. Calder, P. C. (2004) n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin. Sci. (London) 107, 1-11
46. Ruxton, C. H., Reed, S. C., Simpson, M. J., and Millington, K. J. (2004) The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. J. Hum. Nutr. Diet. 17, 449-459
47. Cleland, L. G., James, M. J., and Proudman, S. M. (2003) The role of fish oils in the treatment of rheumatoid arthritis. Drugs 63, 845-853
48. Lapillonne, A., Clarke, S. D., and Heird, W. C. (2004) Polyunsaturated fatty acids and gene expression. Curr. Opin. Clin. Nutr. Metab. Care 7, 151-156
49. Jump, D. B. (2002) Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr. Opin. Lipidol. 13, 155-164
50. Wang, Y., and Oram, J. F. (2002) Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J. Biol. Chem. 277, 5692-5697
51. Collett, E. D., Davidson, L. A., Fan, Y. Y., Lupton, J. R., and Chapkin, R. S. (2001) n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am. J. Physiol. 280, C1066-C1075
52. Bellenger, J., Bellenger, S., Clement, L., Mandard, S., Diot, C., Poisson, J. P., and Narce, M. (2004) A new hypotensive polyunsaturated fatty acid dietary combination regulates oleic acid accumulation by suppression of stearoyl CoA desaturase 1 gene expression in the SHR model of genetic hypertension. FASEB J. 18, 773-775
53. Gonzalez, B., Iturralde, M., Alava, M. A., Anel, A., and Pineiro, A. (2000) Metabolism of n -9, n -6 and n -3 fatty acids in hepatoma Morris 7777 cells. Preferential accumulation of linoleic acid in cardiolipin. Prostaglandins Leukot. Essent. Fatty Acids 62, 299-306
54. Ikeda, I., Mitsui, K., and Imaizumi, K. (1996) Effect of dietary linoleic, alpha-linolenic and arachidonic acids on lipid metabolism, tissue fatty acid composition and eicosanoid production in rats. J. Nutr. Sci. Vitaminol. (Tokyo) 42, 541-551
55. Kramer, J. A., LeDeaux, J., Butteiger, D., Young, T., Crankshaw, C., Harlow, H., Kier, L., and Bhat, B. G. (2003) Transcription profiling in rat liver in response to dietary docosahexaenoic acid implicates stearoyl-coenzyme a desaturase as a nutritional target for lipid lowering. J. Nutr. 133, 57-66
56. Go, V. L., Butrum, R. R., and Wong, D. A. (2003) Diet, nutrition, and cancer prevention: the postgenomic era. J. Nutr. 133, 3830S-3836S
57. Anderle, P., Farmer, P., Berger, A., and Roberts, M. A. (2004) Nutrigenomic approach to understanding the mechanisms by which dietary long-chain fatty acids induce gene signals and control mechanisms involved in carcinogenesis. Nutrition 20, 103-108
58. Davidson, L. A., Nguyen, D. V., Hokanson, R. M., Callaway, E. S., Isett, R. B., Turner, N. D., Dougherty, E. R., Wang, N., Lupton, J. R., Carroll, R.J., et al. (2004) Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res. 64, 6797-6804
59. Calder, P. C., Davis, J., Yaqoob, P., Pala, H., Thies, F., and Newsholme, E. A. (1998) Dietary fish oil suppresses human colon tumour growth in athymic mice. Clin. Sci. (London) 94, 303-311
60. Chang, W. L., Chapkin, R. S., and Lupton, J. R. (1998) Fish oil blocks azoxymethane-induced rat colon tumorigenesis by increasing cell differentiation and apoptosis rather than decreasing cell proliferation. J. Nutr. 128, 491-497
61. Reyes, N., Reyes, I., Tiwari, R., and Geliebter, J. (2004) Effect of linoleic acid on proliferation and gene expression in the breast cancer cell line T47D. Cancer Lett. 209, 25-35
62. Berger, A., Mutch, D. M., German, J. B., and Roberts, M. A. (2002) Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic and hippocampal gene expression. Lipids Health Dis., 1, 2
63. Narayanan, B. A., Narayanan, N. K., Simi, B., and Reddy, B. S. (2003) Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells. Cancer Res. 63, 972-979
64. Watkins, S. M., Reifsnyder, P. R., Pan, H. J., German, J. B., and Leiter, E. H. (2002) Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J. Lipid Res. 43, 1809-1817
65. Riva, A., and Kohane, I. S. (2004) A SNP-centric database for the investigation of the human genome. BMC Bioinformatics 5(1), 33
66. Ames, B. N. (1999) Cancer prevention and diet: help from single nucleotide polymorphisms. Proc. Natl. Acad. Sci. USA 96, 12216-12218
67. Kornman, K. S., Martha, P. M., and Duff, G. W. (2004) Genetic variations and inflammation: a practical nutrigenomics opportunity. Nutrition 20, 44-49
68. Scriver, C. R. (1988) Nutrient-gene interactions: the gene is not the disease and vice versa. Am. J. Clin. Nutr. 48, 1505-1509
69. Park, E. I., Paisley, E. A., Mangian, H. J., Swartz, D. A., Wu, M. X., O'Morchoe, P. J., Behr, S. R., Visek, W. J., and Kaput, J. (1997) Lipid level and type alter stearoyl CoA desaturase mRNA abundance differently in mice with distinct susceptibilities to diet-influenced diseases. J. Nutr. 127, 566-573
70. Chilton, R. J. (2004) Pathophysiology of coronary heart disease: a brief review. J. Am. Osteopath. Assoc. 104, 5S-8S
71. Ordovas, J. M. (2004) The quest for cardiovascular health in the genomic era: nutrigenetics and plasma lipoproteins. Proc. Nutr. Soc. 63, 145-152
72. Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., MacFarlane, P. W., McKillop, J. H., and Packard, C. J. (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med. 333, 1301-1307
73. Chao, Y., Chen, J. S., Hunt, V. M., Kuron, G. W., Karkas, J*. D., Liou, R., and Alberts, A. W. (1991) Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin. Eur. J. Clin. Pharmacol. 40, S11-S14
74. Deckelbaum, R. J., Fisher, E. A., Winston, M., Kumanyika, S., Lauer, R. M., Pi-Sunyer, F. X., St Jeor, S., Schaefer, E. J., and Weinstein, I. B. (1999) Summary of a scientific conference on preventive nutrition: pediatrics to geriatrics. Circulation 100, 450-456
75. Knoblauch, H., Bauerfeind, A., Krahenbuhl, C., Daury, A., Rohde, K., Bejanin, S., Essioux, L., Schuster, H., Luft, F. C., and Reich, J. G. (2002) Common haplotypes in five genes influence genetic variance of LDL and HDL cholesterol in the general population. Hum. Mol. Genet. 11, 1477-1485
76. Mar, R., Pajukanta, P., Allayee, H., Groenendijk, M., Dallinga-Thie, G., Krauss, R. M., Sinsheimer, J. S., Cantor, R. M., de Bruin, T. W., and Lusis, A. J. (2004) Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia. Circ. Res. 94, 993-999
77. Ordovas, J. M., and Schaefer, E. J. (2000) Genetic determinants of plasma lipid response to dietary intervention: the role of the APOA1/C3/A4 gene cluster and the APOE gene. Br. J. Nutr. 83, Suppl. 1, S127-S136
78. Carmena-Ramon, R. F., Ordovas, J. M., Ascaso, J. F., Real, J., Priego, M. A., and Carmena, R. (1998) Influence of genetic variation at the apo A-I gene locus on lipid levels and response to diet in familial hypercholesterolemia. Atherosclerosis 139, 107-113
79. Zheng, K. Q., Zhang, S. Z., He, Y., Zhang, L., Zhang, K. L., Huang, D. J., and Sun, Y. (2004) Association between cholesteryl ester transfer protein gene polymorphisms and variations in lipid levels in patients with coronary heart disease. Chin. Med. J. (England) 117, 1288-1292
80. Skoglund-Andersson, C., Ehrenborg, E., Fisher, R. M., Olivecrona, G., Hamsten, A., and Karpe, F. (2003) Influence of common variants in the CETP, LPL, HL and APO E genes on LDL heterogeneity in healthy, middle-aged men. Atherosclerosis 167, 311-317
81. Evans, D., and Beil, F. U. (2003) The association of the R219K polymorphism in the ATP-binding cassette transporter 1 (ABCA1) gene with coronary heart disease and hyperlipidaemia. J. Mol. Med. 81, 264-270
82. Wang, Q. F., Liu, X., O'Connell, J., Peng, Z., Krauss, R. M., Rainwater, D. L., VandeBerg, J. L., Rubin, E. M., Cheng, J. F., and Pennacchio, L. A. (2004) Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons. Hum. Mol. Genet. 13, 1049-1056
83. Ordovas, J. M. (2002) Gene-diet interaction and plasma lipid responses to dietary intervention. Biochem. Soc. Trans. 30, 68-73
84. Gillotte-Taylor, K., Nickel, M., Johnson, W. J., Francone, O. L., Holvoet, P., Lund-Katz, S., Rothblat, G. H., and Phillips, M. C. (2002) Effects of enrichment of fibroblasts with unesterified cholesterol on the efflux of cellular lipids to apolipoprotein A-I. J. Biol. Chem. 277, 11811-11820
85. Feinleib, M., Kannel, W. B., Garrison, R. J., McNamara, P. M., and Castelli, W. P. (1975) The Framingham Offspring Study. Design and preliminary data. Prev. Med. 4, 518-525
86. Ordovas, J. M., Corella, D., Cupples, L. A., Demissie, S., Kelleher, A., Coltell, O., Wilson, P. W., Schaefer, E. J., and Tucker, K. (2002) Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study. Am. J. Clin. Nutr. 75, 38-46
87. Mead, J. R., Irvine, S. A., and Ramji, D. P. (2002) Lipoprotein lipase: structure, function, regulation, and role in disease. J. Mol. Med. 80, 753-769
88. Merkel, M., Eckel, R. H., and Goldberg, I. J. (2002) Lipoprotein lipase: genetics, lipid uptake, and regulation. J. Lipid Res. 43, 1997-2006
89. McGladdery, S. H., and Frohlich, J. J. (2001) Lipoprotein lipase and apoE polymorphisms: relationship to hypertriglyceridemia during pregnancy. J. Lipid Res. 42, 1905-1912
90. Ma, Y. Q., Thomas, G. N., Ng, M. C., Critchley, J. A., Chan, J. C., and Tomlinson, B. (2003) The lipoprotein lipase gene HindIII polymorphism is associated with lipid levels in early-onset type 2 diabetic patients. Metabolism 52, 338-343
91. Jemaa, R., Tuzet, S., Portos, C., Betoulle, D., Apfelbaum, M., and Fumeron, F. (1995) Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int. J. Obes. Relat. Metab. Disord. 19, 270-274
92. Senti, M., Elosua, R., Tomas, M., Sala, J., Masia, R., Ordovas, J. M., Shen, H., and Marrugat, J. (2001) Physical activity modulates the combined effect of a common variant of the lipoprotein lipase gene and smoking on serum triglyceride levels and high-density lipoprotein cholesterol in men. Hum. Genet. 109, 385-392
93. Jemaa, R., Tuzet, S., Betoulle, D., Apfelbaum, M., and Fumeron, F. (1997) Hind III polymorphism of the lipoprotein lipase gene and plasma lipid response to low calorie diet. Int. J. Obes. Relat. Metab. Disord. 21, 280-283
94. Parillo, M., and Riccardi, G. (2004) Diet composition and the risk of type 2 diabetes: epidemiological and clinical evidence. Br. J. Nutr. 92, 7-19
95. Krauss, R. M., and Siri, P. W. (2004) Dyslipidemia in type 2 diabetes. Med. Clin. North Am. 88, 897-909 (x)
96. West, K. M., and Kalbfleish, J. M. (1971) Influence of nutritional factors on prevalence of diabetes. Diabetes 20, 99-108
97. Wood, P. A. (2004) Genetically modified mouse models for disorders of fatty acid metabolism: pursuing the nutrigenomics of insulin resistance and type 2 diabetes. Nutrition 20, 121-126
98. Tai, E. S., Corella, D., Demissie, S., Cupples, L. A., Coltell, O., Schaefer, E. J., Tucker, K. L., and Ordovas, J. M. (2005) Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study. J. Nutr. 135, 397-403
99. Filippi, E., Sentinelli, F., Trischitta, V., Romeo, S., Area, M., Leonetti, F., Di Mario, U., and Baroni, M. G. (2004) Association of the human adiponectin gene and insulin resistance. Eur. J. Hum. Genet. 12, 199-205
100. Smith, S. R., Bai, F., Charbonneau, C., Janderova, L., and Argyropoulos, G. (2003) A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52, 1611-1618
101. Horton, J. D., Shah, N. A., Warrington, J. A., Anderson, N. N., Park, S. W., Brown, M. S., and Goldstein, J. L. (2003) Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. USA 100, 12027-12032
102. Horton, J. D., Goldstein, J. L., and Brown, M. S. (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131
103. Shimano, H., Horton, J. D., Shimomura, I., Hammer, R. E., Brown, M. S., and Goldstein, J. L. (1997) Isoform 1c of sterol regulatory element binding protein is less active than isoform la in livers of transgenic mice and in cultured cells. J. Clin. Invest. 99, 846-854
104. Shimomura, I., Hammer, R. E., Richardson, J. A., Ikemoto, S., Bashmakov, Y., Goldstein, J. L., and Brown, M. S. (1998) Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12, 3182-3194
105. Laudes, M., Barroso, I., Luan, J., Soos, M. A., Yeo, G., Meirhaeghe, A., Logie, L., Vidal-Puig, A., Schafer, A. J., Wareham, N. J., et al. (2004) Genetic variants in human sterol regulatory element binding protein-1c in syndromes of severe insulin resistance and type 2 diabetes. Diabetes 53, 842-846
106. Nagata, R., Nishio, Y., Sekine, O., Nagai, Y., Maeno, Y., Ugi, S., Maegawa, H., and Kashiwagi, A. (2004) Single nucleotide polymorphism (-468 Gly to A) at the promoter region of SREBP-1c associates with genetic defect of fructose-induced hepatic lipogenesis. J. Biol. Chem. 279, 29031-29042 (corrected)
107. Hihi, A. K., Michalik, L., and Wahli, W. (2002) PPARs: transcriptional effectors of fatty acids and their derivatives. Cell. Mol. Life Sci. 59, 790-798
108. Kersten, S., and Wahli, W. (2000) Peroxisome proliferator activated receptor agonists. EXS 89, 141-151
109. Wahli, W., Braissant, O., and Desvergne, B. (1995) Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more. Chem. Biol. 2, 261-266
110. Tan, N. S., Michalik, L., Di-Poi, N., Desvergne, B., and Wahli, W. (2004) Critical roles of the nuclear receptor PPARbeta (peroxisome-proliferator- activated receptor beta) in skin wound healing. Biochem. Soc. Trans. 32, 97-102
111. Desvergne, B., Michalik, L., and Wahli, W. (2004) Be fit or be sick: peroxisome proliferator-activated receptors are down the road. Mol. Endocrinol. 18, 1321-1332
112. Vidal-Puig, A., Jimenez-Linan, M., Lowell, B. B., Hamann, A., Hu, E., Spiegelman, B., Flier, J. S., and Moller, D. E. (1996) Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J. Clin. Invest. 97, 2553-2561
113. Mao-Qiang, M., Fowler, A. J., Schmuth, M., Láu, P., Chang, S., Brown, B. E., Moser, A. H., Michalik, L., Desvergne, B., Wahli, W., et al. (2004) Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation. J. Invest. Dermatol. 123, 305-312
114. Yu, S., Matsusue, K., Kashireddy, P., Cao, W. Q., Yeldandi, V., Yeldandi, A. V., Rao, M. S., Gonzalez, F. J., and Reddy, J. K. (2003) Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J. Biol. Chem. 278, 498-505
115. Miles, P. D., Barak, Y., He, W., Evans, R. M., and Olefsky, J. M. (2000) Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J. Clin. Invest. 105, 287-292
116. Rieusset, J., Touri, F., Michalik, L., Escher, P., Desvergne, B., Niesor, E., and Wahli, W. (2002) A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity. Mol. Endocrinol. 16, 2628-2644
117. Matsusue, K., Haluzik, M., Lambert, G., Yim, S. H., Gavrilova, O., Ward, J. M., Brewer, B., Jr., Reitman, M. L., and Gonzalez, F. J. (2003) Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J. Clin. Invest. 111, 737-747
118. Doney, A., Fischer, B., Frew, D., Cumming, A., Flavell, D. M., World, M., Montgomery, H. E., Boyle, D., Morris, A., and Palmer, C. N. (2002) Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genet. 3(1), 21
119. Li, S., Chen, W., Srinivasan, S. R., Boerwinkle, E., and Berenson, G. S. (2003) The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study. Diabetes 52, 1265-1269
120. Doney, A. S., Fischer, B., Leese, G., Morris, A. D., and Palmer, C. N. (2004) Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus. A Go-DARTS Study. Arterioscler. Thromb. Vasc. Biol.
121. Swarbrick, M. M., Chapman, C. M., McQuillan, B. M., Hung, J., Thompson, P. L., and Beilby, J. P. (2001) A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity. Eur. J. Endocrinol. 144, 277-282
122. Valve, R., Sivenius, K., Miettinen, R., Pihlajamaki, J., Rissanen, A., Deeb, S. S., Auwerx, J., Uusitupa, M., and Laakso, M. (1999) Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women. J. Clin. Endocrinol. Metab. 84, 3708-3712
123. Luan, J., Browne, P. O., Harding, A. H., Halsall, D. J., O'Rahilly, S., Chatterjee, V. K., and Wareham, N. J. (2001) Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes 50, 686-689
124. Dressman, J. B., Bass, P., Ritschel, W. A., Friend, D. R., Rubinstein, A., and Ziv, E. (1993) Gastrointestinal parameters that influence oral medications. J. Pharm. Sci. 82, 857-872
125. Schneeman, B. O. (2002) Gastrointestinal physiology and functions. Br. J. Nutr. 88, Suppl. 2, S159-S163
126. Backhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., and Gordon, J. I. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 101, 15718-15723
127. Carr, T. P., Gallaher, D. D., Yang, C. H., and Hassel, C. A. (1996) Increased intestinal contents viscosity reduces cholesterol absorption efficiency in hamsters fed hydroxypropyl methylcellulose. J. Nutr. 126, 1463-1469
128. Marzolini, C., Tirona, R. G., and Kim, R. B. (2004) Pharmacogenomics of the OATP and OAT families. Pharmacogenomics 5, 273-282
129. Ishikawa, T., Tsuji, A., Inui, K., Sai, Y., Anzai, N., Wada, M., Endou, H., and Sumino, Y. (2004) The genetic polymorphism of drug transporters: functional analysis approaches. Pharmacogenomics 5, 67-99
130. Dietrich, C. G., Geier, A., and Oude Elferink, R. P. (2003) ABC of oral bioavailability: transporters as gatekeepers in the gut. Gut 52, 1788-1795
131. Pratley, R. E., Baier, L., Pan, D. A., Salbe, A. D., Storlien, L., Ravussin, E., and Bogardus, C. (2000) Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J. Lipid Res. 41, 2002-2008
132. Besnard, P., Niot, I., Poirier, H., Clement, L., and Bernard, A. (2002) New insights into the fatty acid-binding protein (FABP) family in the small intestine. Mol. Cell. Biochem. 239, 139-147
133. Darimont, C., Gradoux, N., Persohn, E., Cumin, F., and De Pover, A. (2000) Effects of intestinal fatty acid-binding protein overexpression on fatty acid metabolism in Caco-2 cells. J. Lipid Res. 41, 84-92
134. Baier, L. J., Sacchettini, J. C., Knowler, W. C., Eads, J., Paolisso, G., Tataranni, P. A., Mochizuki, H., Bennett, P. H., Bogardus, C., and Prochazka, M. (1995) An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J. Clin. Invest. 95, 1281-1287
135. Baier, L. J., Bogardus, C., and Sacchettini, J. C. (1996) A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J. Biol. Chem. 271, 10892-10896
136. Agren, J. J., Vidgren, H. M., Valve, R. S., Laakso, M., and Uusitupa, M. I. (2001) Postprandial responses of individual fatty acids in subjects homozygous for the threonine- or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene. Am. J. Clin. Nutr. 73, 31-35
137. Desiere, F. (2004) Towards a systems biology understanding of human health: Interplay between genotype, environment and nutrition. Biotechnol. Annu. Rev. 10, 51-84
138. Clish, C. B., Davidov, E., Oresic, M., Plasterer, T. N., Lavine, G., Londo, T., Meys, M., Snell, P., Stochaj, W., Adourian, A., et al. (2004) Integrative biological analysis of the APOE*3-leiden transgenic mouse. OMICS 8, 3-13
139. Coen, M., Ruepp, S. U., Lindon, J. C., Nicholson, J. K., Pognan, F., Lenz, E. M., and Wilson, I. D. (2004) Integrated application of transcriptomics and metabonomics yields new insight into the toxicity due to paracetamol in the mouse. J. Pharm. Biomed. Anal. 35, 93-105
140. Miklos, G. L., and Maleszka, R. (2004) Microarray reality checks in the context of a complex disease. Nat. Biotechnol. 22, 615-621
141. Goodacre, R., Vaidyanathan, S., Dunn, W. B., Harrigan, G. G., and Kell, D. B. (2004) Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol. 22, 245-252
142. German, J. B., Roberts, M. A., Fay, L., and Watkins, S. M. (2002) Metabolomics and individual metabolic assessment: the next great challenge for nutrition. J. Nutr. 132, 2486-2487
143. German, J. B., Roberts, M. A., and Watkins, S. M. (2003) Genomics and metabolomics as markers for the interaction of diet and health: lessons from lipids. J. Nutr. 133, 2078S-2083S
144. German, J. B., Bauman, D. E., Burrin, D. G., Failla, M. L., Freake, H. C., King, J. C., Klein, S., Milner, J. A., Pelto, G. H., Rasmussen, K. M., et al. (2004) Metabolomics in the opening decade of the 21st century: building the roads to individualized health. J. Nutr. 134, 2729-2732
145. Swierczynska, M., Nizankowska-Mogilnicka, E., Zarychta, J., Gielicz, A., and Szczeklik, A. (2003) Nasal versus bronchial and nasal response to oral aspirin challenge: Clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis. J. Allergy Clin. Immunol. 112, 995-1001
146. Benowitz, N. L., Peng, M., and Jacob, P., III (2003) Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism. Clin. Pharmacol. Ther. 74, 468-474
147. Roberts, C. K., Vaziri, N. D., and Barnard, R. J. (2002) Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation 106, 2530-2532